Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methods for external control groups for single arm trials or
long‐term
uncontrolled extensions to randomized clinical trials
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-23
DOI
10.1002/pds.5141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- When Context Is Hard to Come By: External Comparators and How to Use Them
- (2020) Christina Mack et al. Therapeutic Innovation & Regulatory Science
- A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data
- (2020) Christen M. Gray et al. DRUG SAFETY
- Sharing Historical Trial Data to Accelerate Clinical Development
- (2019) Perry T. Yin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covariate-adjusted borrowing of historical control data in randomized clinical trials
- (2017) Baoguang Han et al. PHARMACEUTICAL STATISTICS
- Estimating the population-level impact of vaccines using synthetic controls
- (2017) Christian A. W. Bruhn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Using register data to estimate causal effects of interventions: An ex post synthetic control-group approach
- (2017) Magnus Bygren et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Missing data and multiple imputation in clinical epidemiological research
- (2017) Alma Pedersen et al. Clinical Epidemiology
- Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
- (2016) Miguel A. Hernán et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Emergence of the Randomized, Controlled Trial
- (2016) Laura E. Bothwell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
- (2016) N Gökbuget et al. Blood Cancer Journal
- FDA Approval: Blinatumomab
- (2015) D. Przepiorka et al. CLINICAL CANCER RESEARCH
- The role of nonrandomized trials in the evaluation of oncology drugs
- (2015) R Simon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Multiple Imputation
- (2015) Peng Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Why Did the Randomized Clinical Trial Become the Primary Focus of My Career?
- (2015) David L. Sackett VALUE IN HEALTH
- Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics
- (2012) Sengwee Toh et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort
- (2010) J. W. Hiemenz et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- Patient Registries of Acute Coronary Syndrome
- (2009) Ignacio Ferreira-González et al.
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now